Helix BioMedix, Inc. Reports Another Revenue Record in the Second Quarter 2011

August 5, 2011 |

1 min read

BOTHELL, Wash.--(BUSINESS WIRE)--Helix BioMedix, Inc. (OTCQB: HXBM), a developer of bioactive peptides, today announced financial results for the company’s second quarter ended June 30, 2011.

Earnings

MORE ON THIS TOPIC

Blindness and crisis, blindfolded businessman walks to the cliff

Earnings

Merck looks ahead to ‘another year of investment’ as Keytruda cliff looms

October 29, 2026

·

4 min read

·

Heather McKenzie

pipeline infographic, industrial background, oil water gas transportation yellow pipes, plumbing system vector illustration

Earnings

BMS drops Prothena-partnered neuro drug, sales outlook improves on a Q3 beat

October 29, 2026

·

4 min read

·

Gabrielle Masson

Illustration of cardboard box filled with office supplies, a computer keyboard, lamp, and a potted plant

Layoff Tracker

LENZ cuts 75% of staff as third quarter earnings disappoint

October 29, 2026

·

111 min read

·

BioSpace Editorial Staff

Target, miss the target, target shooting, dart, correct decisions, bow and arrow, dart on target, hits and misses (3d illustration)

Neuroscience

Ono cans 2 endocannabinoid drug studies after quintuple Phase 2 failure

October 29, 2026

·

1 min read

·

Annalee Armstrong